Protein phosphatase 2A (PP2A) is one main serine/threonine phosphatase in eukaryotes, and its activation changes have been linked to modulation of numerous pathological processes, such as cancer, inflammation, fibrosis, and neurodegenerative diseases. Acute respiratory distress syndrome (ARDS), the major cause of respiratory failure, remains with limited therapies available up to now. Alveolar macrophages (AMs) are essential to innate immunity and host defense, participating in the pathogenesis of ARDS. As a result, AMs are considered as a potential therapeutic target for ARDS. In our study, we firstly found that PP2A activity was significantly decreased in the lipopolysaccharide (LPS)-stimulated AMs. Furthermore, adoptive transfer of AMs with enhanced PP2A enzyme activity that was improved by C2-ceramide prior to LPS exposure alleviated acute lung inflammation. Conversely, AM-specific ablation of PP2ACα exacerbated inflammatory responses to LPS. Mechanistically, PP2ACα negatively regulates LPS-induced cytokine secretion of AMs by NF-κB and MAPK pathways. Together, these findings provide the evidence to guide the development of novel therapeutic options targeting PP2ACα for ARDS/acute lung injury.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Matthay, M.A., L.B. Ware, and G.A. Zimmerman. 2012. The acute respiratory distress syndrome. The Journal of Clinical Investigation 122 (8): 2731–2740.
Brochard, L., A. Slutsky, and A. Pesenti. 2017. Mechanical ventilation to minimize progression of lung injury in acute respiratory failure. American Journal of Respiratory and Critical Care Medicine 195 (4): 438–442.
Matthay, M.A., G.A. Zimmerman, C. Esmon, J. Bhattacharya, B. Coller, C.M. Doerschuk, J. Floros, M.A. Gimbrone Jr., E. Hoffman, R.D. Hubmayr, M. Leppert, S. Matalon, R. Munford, P. Parsons, A.S. Slutsky, K.J. Tracey, P. Ward, D.B. Gail, and A.L. Harabin. 2003. Future research directions in acute lung injury: Summary of a national heart, lung, and blood institute working group. American Journal of Respiratory and Critical Care Medicine 167 (7): 1027–1035.
Dai, H., L. Pan, F. Lin, et al. 2015. Mechanical ventilation modulates toll-like receptors 2, 4, and 9 on alveolar macrophages in a ventilator-induced lung injury model. The Journal of Thoracic Disease 7 (4): 616–624.
Gordon, S. 2003. Alternative activation of macrophages. Nature Reviews. Immunology 3 (1): 23–35.
Aggarwal, N.R., L.S. King, and F.R. D’Alessio. 2014. Diverse macrophage populations mediate acute lung inflammation and resolution. American Journal of Physiology. Lung Cellular and Molecular Physiology 306 (8): L709–L725.
Dagvadorj, J., K. Shimada, S. Chen, H.D. Jones, G. Tumurkhuu, W. Zhang, K.A. Wawrowsky, T.R. Crother, and M. Arditi. 2015. Lipopolysaccharide induces alveolar macrophage necrosis via CD14 and the P2X7 receptor leading to interleukin-1alpha release. Immunity 42 (4): 640–653.
Holt, P.G., D.H. Strickland, M.E. Wikstrom, et al. 2008. Regulation of immunological homeostasis in the respiratory tract. Nature Reviews Immunology 8 (2): 142–152.
Kolaczkowska, E., and P. Kubes. 2013. Neutrophil recruitment and function in health and inflammation. Nature Reviews Immunology 13 (3): 159–175.
Matute-Bello, G., G. Downey, B.B. Moore, S.D. Groshong, M.A. Matthay, A.S. Slutsky, and W.M. Kuebler. 2011. An official American Thoracic Society workshop report: Features and measurements of experimental acute lung injury in animals. American Journal of Respiratory Cell and Molecular Biology 44 (5): 725–738.
Arora, S., K. Dev, B. Agarwal, P. Das, and M.A. Syed. 2018. Macrophages: Their role, activation and polarization in pulmonary diseases. Immunobiology 223 (4–5): 383–396.
Vergadi, E., K. Vaporidi, E.E. Theodorakis, C. Doxaki, E. Lagoudaki, E. Ieronymaki, V.I. Alexaki, M. Helms, E. Kondili, B. Soennichsen, E.N. Stathopoulos, A.N. Margioris, D. Georgopoulos, and C. Tsatsanis. 2014. Akt2 deficiency protects from acute lung injury via alternative macrophage activation and miR-146a induction in mice. Journal of Immunology 192 (1): 394–406.
Orfanos, S.E., I. Mavrommati, I. Korovesi, et al. 2004. Pulmonary endothelium in acute lung injury: From basic science to the critically ill. Intensive Care Medicine 30 (9): 1702–1714.
Tsushima, K., L.S. King, N.R. Aggarwal, A. de Gorordo, F.R. D’Alessio, and K. Kubo. 2009. Acute lung injury review. Internal Medicine 48 (9): 621–630.
Sun, L., T.T. Pham, T.T. Cornell, K.L. McDonough, W.M. McHugh, N.B. Blatt, M.K. Dahmer, and T.P. Shanley. 2017. Myeloid-specific gene deletion of protein phosphatase 2A magnifies MyD88- and TRIF-dependent inflammation following endotoxin challenge. Journal of Immunology 198 (1): 404–416.
Kawasaki, T., and T. Kawai. 2014. Toll-like receptor signaling pathways. Frontiers in Immunology 5: 461.
Lopez-Bojorquez, L.N., A.Z. Dehesa, and G. Reyes-Teran. 2004. Molecular mechanisms involved in the pathogenesis of septic shock. Archives of Medical Research 35 (6): 465–479.
Zong, X., D. Song, T. Wang, X. Xia, W. Hu, F. Han, and Y. Wang. 2015. LFP-20, a porcine lactoferrin peptide, ameliorates LPS-induced inflammation via the MyD88/NF-kappaB and MyD88/MAPK signaling pathways. Developmental and Comparative Immunology 52 (2): 123–131.
Shi, Y. 2009. Serine/threonine phosphatases: Mechanism through structure. Cell 139 (3): 468–484.
Chen, Y., Y. Xu, Q. Bao, Y. Xing, Z. Li, Z. Lin, J.B. Stock, P.D. Jeffrey, and Y. Shi. 2007. Structural and biochemical insights into the regulation of protein phosphatase 2A by small t antigen of SV40. Nature Structural & Molecular Biology 14 (6): 527–534.
McHugh, W.M., W.W. Russell, A.J. Fleszar, P.E. Rodenhouse, S.P. Rietberg, L. Sun, T.P. Shanley, and T.T. Cornell. 2016. Protein phosphatase 2A activation attenuates inflammation in murine models of acute lung injury. American Journal of Physiology. Lung Cellular and Molecular Physiology 311 (5): L903–L912.
Yadav, H., S. Devalaraja, S.T. Chung, and S.G. Rane. 2017. TGF-beta1/Smad3 pathway targets PP2A-AMPK-FoxO1 signaling to regulate hepatic gluconeogenesis. Journal of Biological Chemistry 292 (8): 3420–3432.
Szymiczek, A., S. Pastorino, D. Larson, M. Tanji, L. Pellegrini, J. Xue, S. Li, C. Giorgi, P. Pinton, Y. Takinishi, H.I. Pass, H. Furuya, G. Gaudino, A. Napolitano, M. Carbone, and H. Yang. 2017. FTY720 inhibits mesothelioma growth in vitro and in a syngeneic mouse model. Journal of Translational Medicine 15 (1): 58.
Guo, X., T. Li, Y. Xu, X. Xu, Z. Zhu, Y. Zhang, J. Xu, K. Xu, H. Cheng, X. Zhang, and Y. Ke. 2017. Increased levels of Gab1 and Gab2 adaptor proteins skew interleukin-4 (IL-4) signaling toward M2 macrophage-driven pulmonary fibrosis in mice. Journal of Biological Chemistry 292 (34): 14003–14015.
Van Rooijen, N. and A. Sanders. 1994. Liposome mediated depletion of macrophages: Mechanism of action, preparation of liposomes and applications. Journal of Immunological Methods 174(1–2): 83–93.
Celus, W., G. Di Conza, A.I. Oliveira, et al. 2017. Loss of caveolin-1 in metastasis-associated macrophages drives lung metastatic growth through increased angiogenesis. Cell Reports 21 (10): 2842–2854.
Zhang, Y., Y. Xu, S. Liu, X. Guo, D. Cen, J. Xu, H. Li, K. Li, C. Zeng, L. Lu, Y. Zhou, H. Shen, H. Cheng, X. Zhang, and Y. Ke. 2016. Scaffolding protein Gab1 regulates myeloid dendritic cell migration in allergic asthma. Cell Research 26 (11): 1226–1241.
Sents, W., B. Meeusen, P. Kalev, E. Radaelli, X. Sagaert, E. Miermans, D. Haesen, C. Lambrecht, M. Dewerchin, P. Carmeliet, J. Westermarck, A. Sablina, and V. Janssens. 2017. PP2A inactivation mediated by PPP2R4 haploinsufficiency promotes cancer development. Cancer Research 77 (24): 6825–6837.
Arroyo, J.D., and W.C. Hahn. 2005. Involvement of PP2A in viral and cellular transformation. Oncogene 24 (52): 7746–7755.
Arif, M., J. Wei, Q. Zhang, F. Liu, G. Basurto-Islas, I. Grundke-Iqbal, and K. Iqbal. 2014. Cytoplasmic retention of protein phosphatase 2A inhibitor 2 (I2PP2A) induces Alzheimer-like abnormal hyperphosphorylation of Tau. Journal of Biological Chemistry 289 (40): 27677–27691.
Corcoran, N.M., D. Martin, B. Hutter-Paier, M. Windisch, T. Nguyen, L. Nheu, L.E. Sundstrom, A.J. Costello, and C.M. Hovens. 2010. Sodium selenate specifically activates PP2A phosphatase, dephosphorylates tau and reverses memory deficits in an Alzheimer’s disease model. Journal of Clinical Neuroscience 17 (8): 1025–1033.
Zhang, Y., X. Jiang, C. Qin, S. Cuevas, P.A. Jose, and I. Armando. 2016. Dopamine D2 receptors' effects on renal inflammation are mediated by regulation of PP2A function. American Journal of Physiology. Renal Physiology 310 (2): F128–F134.
Andonegui, G., H. Zhou, D. Bullard, et al. 2009. Mice that exclusively express TLR4 on endothelial cells can efficiently clear a lethal systemic gram-negative bacterial infection. The Journal of Clinical Investigation 119 (7): 1921–1930.
Jayne, J.G., T.J. Bensman, J.B. Schaal, A.Y.J. Park, E. Kimura, D. Tran, M.E. Selsted, and P.M. Beringer. 2018. Rhesus theta-defensin-1 attenuates endotoxin-induced acute lung injury by inhibiting proinflammatory cytokines and neutrophil recruitment. American Journal of Respiratory Cell and Molecular Biology 58 (3): 310–319.
Soni, S., M.R. Wilson, K.P. O'Dea, M. Yoshida, U. Katbeh, S.J. Woods, and M. Takata. 2016. Alveolar macrophage-derived microvesicles mediate acute lung injury. Thorax 71 (11): 1020–1029.
Hatchwell, L., J. Girkin, M.D. Dun, M. Morten, N. Verrills, H.D. Toop, J.C. Morris, S.L. Johnston, P.S. Foster, A. Collison, and J. Mattes. 2014. Salmeterol attenuates chemotactic responses in rhinovirus-induced exacerbation of allergic airways disease by modulating protein phosphatase 2A. The Journal of Allergy and Clinical Immunology 133 (6): 1720–1727.
Li, J.J., H.L. Tay, S. Maltby, Y. Xiang, F. Eyers, L. Hatchwell, H. Zhou, H.D. Toop, J.C. Morris, P. Nair, J. Mattes, P.S. Foster, and M. Yang. 2015. MicroRNA-9 regulates steroid-resistant airway hyperresponsiveness by reducing protein phosphatase 2A activity. The Journal of Allergy and Clinical Immunology 136 (2): 462–473.
Wallace, A.M., A. Hardigan, P. Geraghty, S. Salim, A. Gaffney, J. Thankachen, L. Arellanos, J.M. D'Armiento, and R.F. Foronjy. 2012. Protein phosphatase 2A regulates innate immune and proteolytic responses to cigarette smoke exposure in the lung. Toxicological Sciences 126 (2): 589–599.
Geraghty, P., E. Eden, M. Pillai, et al. 2014. alpha1-Antitrypsin activates protein phosphatase 2A to counter lung inflammatory responses. Am J Respir Crit Care Med. 190(11): 1229–1242.
Joh, E.H., W. Gu, and D.H. Kim. 2012. Echinocystic acid ameliorates lung inflammation in mice and alveolar macrophages by inhibiting the binding of LPS to TLR4 in NF-kappaB and MAPK pathways. Biochemical Pharmacology 84 (3): 331–340.
Yang, J., G.H. Fan, B.E. Wadzinski, H. Sakurai, and A. Richmond. 2001. Protein phosphatase 2A interacts with and directly dephosphorylates RelA. Journal of Biological Chemistry 276 (51): 47828–47833.
Zhao, B., L. Sun, M. Haas, et al. 2008. PP2A regulates upstream members of the c-jun N-terminal kinase mitogen-activated protein kinase signaling pathway. Shock 29 (2): 181–188.
Sun, L., G. Stoecklin, S. Van Way, et al. 2007. Tristetraprolin (TTP)-14-3-3 complex formation protects TTP from dephosphorylation by protein phosphatase 2a and stabilizes tumor necrosis factor-alpha mRNA. Journal of Biological Chemistry 282 (6): 3766–3777.
Cao, L., R. Li, X. Chen, et al. 2016. Neougonin a inhibits lipopolysaccharide-induced inflammatory responses via downregulation of the NF-kB signaling pathway in RAW 264.7 macrophages. Inflammation 39 (6): 1939–1948.
Lai, J.L., Y.H. Liu, C. Liu, M.P. Qi, R.N. Liu, X.F. Zhu, Q.G. Zhou, Y.Y. Chen, A.Z. Guo, and C.M. Hu. 2017. Indirubin inhibits LPS-induced inflammation via TLR4 abrogation mediated by the NF-kB and MAPK signaling pathways. Inflammation 40 (1): 1–12.
Jung, J.S., K.O. Shin, Y.M. Lee, J.A. Shin, E.M. Park, J. Jeong, D.H. Kim, J.W. Choi, and H.S. Kim. 2013. Anti-inflammatory mechanism of exogenous C2 ceramide in lipopolysaccharide-stimulated microglia. Biochimica et Biophysica Acta 1831 (6): 1016–1026.
We thank Dr. Xiang Gao (Nanjing University, Nanjing, China) for the PP2ACαf/f mice and Dr. Ximei-Wu (Zhejiang University, Hangzhou, China) for the LysMcre mice.
This work was supported by The National Natural Science Foundation of China 81700022 to Y.Z., The National Key Research and Development Plan 2018YFC1705500 to C.P., Research fund of Zhejiang Chinese Medical University 111100E013/001/001/029 and 111100E013/001/001/066 to Y.Z.
Conflict of Interest
The authors declare that they have no conflict of interest.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
He, Z., Du, L., Ke, Y. et al. PP2ACα of Alveolar Macrophages Is a Novel Protective Factor for LPS-Induced Acute Respiratory Distress Syndrome. Inflammation 42, 1004–1014 (2019). https://doi.org/10.1007/s10753-019-00962-x
- Alveolar macrophages
- Acute respiratory distress syndrome